Ultragenyx Pharmaceutical Inc.
Hedge Funds Holdings
Last updated:
Ultragenyx Pharmaceutical Inc.‘s stocks are currently a part of 204 hedge funds’ portfolios, which represents 90.08% of the total amount of its stocks outstanding. This makes up a total of 61.14M shares of Ultragenyx Pharmaceutical Inc.. Compared to the previous quarter, the number fell by -8.47% or -5.65M shares fewer. As for the holding position changes, 41.18% (84) of current hedge fund investors increased the number of shares held, 27.45% (56) of current holders sold a part of the shares held, and 16.67% (34) closed the holdings completely. 41 hedge funds are new holders of Ultragenyx Pharmaceutical Inc. stock in Q3 2022, it is 20.1% of total holders.
Hedge funds holding Ultragenyx Pharmaceutical (Q4 2017 – Q3 2022)
| Q4 2017 | 160 |
|---|---|
| Q1 2018 | 160 |
| Q2 2018 | 153 |
| Q3 2018 | 172 |
| Q4 2018 | 156 |
| Q1 2019 | 171 |
| Q2 2019 | 166 |
| Q3 2019 | 168 |
| Q4 2019 | 170 |
| Q1 2020 | 169 |
| Q2 2020 | 189 |
| Q3 2020 | 202 |
| Q4 2020 | 248 |
| Q1 2021 | 248 |
| Q2 2021 | 234 |
| Q3 2021 | 215 |
| Q4 2021 | 224 |
| Q1 2022 | 231 |
| Q2 2022 | 211 |
| Q3 2022 | 204 |
Hedge funds changes in Ultragenyx Pharmaceutical positions (Q4 2017 – Q3 2022)
| Q4 2017 | 31 | 57 | 46 | 21 | 5 |
|---|---|---|---|---|---|
| Q1 2018 | 27 | 69 | 38 | 22 | 4 |
| Q2 2018 | 21 | 54 | 56 | 27 | -5 |
| Q3 2018 | 35 | 47 | 59 | 14 | 17 |
| Q4 2018 | 20 | 65 | 51 | 35 | -15 |
| Q1 2019 | 31 | 88 | 29 | 17 | 6 |
| Q2 2019 | 22 | 72 | 43 | 25 | 4 |
| Q3 2019 | 27 | 74 | 45 | 22 | 0 |
| Q4 2019 | 28 | 71 | 48 | 24 | -1 |
| Q1 2020 | 27 | 68 | 47 | 24 | 3 |
| Q2 2020 | 35 | 65 | 65 | 15 | 9 |
| Q3 2020 | 34 | 83 | 64 | 21 | 0 |
| Q4 2020 | 62 | 95 | 70 | 18 | 3 |
| Q1 2021 | 40 | 87 | 96 | 35 | -10 |
| Q2 2021 | 42 | 78 | 86 | 56 | -28 |
| Q3 2021 | 24 | 83 | 78 | 40 | -10 |
| Q4 2021 | 32 | 93 | 69 | 20 | 10 |
| Q1 2022 | 39 | 85 | 72 | 29 | 6 |
| Q2 2022 | 28 | 86 | 69 | 46 | -18 |
| Q3 2022 | 41 | 84 | 56 | 34 | -11 |
Hedge funds changes in Ultragenyx Pharmaceutical stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 5,252,000 | 8,423,000 |
|---|---|---|
| Q1 2018 | 1,035,000 | 9,621,000 |
| Q2 2018 | 13,168,000 | 14,232,000 |
| Q3 2018 | 40,360,000 | 6,552,000 |
| Q4 2018 | 1,869,000 | 2,442,000 |
| Q1 2019 | 22,687,000 | 11,188,000 |
| Q2 2019 | 10,427,000 | 9,370,000 |
| Q3 2019 | 3,127,000 | 7,742,000 |
| Q4 2019 | 1,781,000 | 12,335,000 |
| Q1 2020 | 13,390,000 | 12,325,000 |
| Q2 2020 | 21,440,000 | 14,072,000 |
| Q3 2020 | 5,908,000 | 2,924,000 |
| Q4 2020 | 59,620,000 | 16,253,000 |
| Q1 2021 | 47,255,000 | 17,942,000 |
| Q2 2021 | 6,378,000 | 7,518,000 |
| Q3 2021 | 3,590,000 | 4,897,000 |
| Q4 2021 | 874,000 | 8,006,000 |
| Q1 2022 | 7,005,000 | 15,149,000 |
| Q2 2022 | 12,618,000 | 14,667,000 |
| Q3 2022 | 15,684,000 | 12,088,000 |